Du Toit Jessica, Millum Joseph
National Institutes of Health, Bethesda, Maryland, USANational Institutes of Health, Bethesda, Maryland, USA
National Institutes of Health, Bethesda, Maryland, USANational Institutes of Health, Bethesda, Maryland, USA.
J Med Philos. 2016 Oct;41(5):540-57. doi: 10.1093/jmp/jhw018. Epub 2016 Jul 26.
When allocating scarce healthcare resources, the expected benefits of alternative allocations matter. But, there are different kinds of benefits. Some are direct benefits to the recipient of the resource such as the health improvements of receiving treatment. Others are indirect benefits to third parties such as the economic gains from having a healthier workforce. This article considers whether only the direct benefits of alternative healthcare resource allocations are relevant to allocation decisions, or whether indirect benefits are relevant too. First, we distinguish different conceptions of direct and indirect benefits and argue that only a recipient conception could be morally relevant. We analyze four arguments for thinking that indirect benefits should not count and argue that none is successful in showing that the indirectness of a benefit is a good reason not to count it. We conclude that direct and indirect benefits should be evaluated in the same way.
在分配稀缺的医疗资源时,不同分配方式的预期效益至关重要。但是,效益有不同种类。有些是对资源接受者的直接效益,比如接受治疗后健康状况的改善。其他的则是对第三方的间接效益,比如拥有更健康的劳动力所带来的经济收益。本文探讨的是,在医疗资源分配决策中,是否只有不同分配方式的直接效益才相关,还是间接效益也同样相关。首先,我们区分了直接效益和间接效益的不同概念,并认为只有接受者概念在道德层面才可能相关。我们分析了四种认为间接效益不应计算在内的观点,并认为没有一种观点能成功表明效益的间接性是不将其计算在内的充分理由。我们的结论是,直接效益和间接效益应以相同方式进行评估。